Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer
Conditions: Metastatic Clear Cell Renal Cell Carcinoma; With Positive PSMA Expression at Tumor Sites Interventions: Drug: 177Lu-PSMA-1 (radiopharmaceutical) Sponsors: Centre Leon Berard Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Renal Cell Carcinoma | Research | Study